Justified Concern or Exaggerated Fear: The Risk of Anaphylaxis in Percutaneous Treatment of Cystic Echinococcosis—A Systematic Literature Review
Open Access
- 14 June 2011
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Neglected Tropical Diseases
- Vol. 5 (6) , e1154
Abstract
Percutaneous treatment (PT) emerged in the mid-1980s as an alternative to surgery for selected cases of abdominal cystic echinococcosis (CE). Despite its efficacy and widespread use, the puncture of echinococcal cysts is still far from being universally accepted. One of the main reasons for this reluctance is the perceived risk of anaphylaxis linked to PTs. To quantify the risk of anaphylactic reactions and lethal anaphylaxis with PT, we systematically searched MEDLINE for publications on PT of CE and reviewed the PT-related complications. After including 124 publications published between 1980 and 2010, we collected a total number of 5943 PT procedures on 5517 hepatic and non-hepatic echinococcal cysts. Overall, two cases of lethal anaphylaxis and 99 reversible anaphylactic reactions were reported. Lethal anaphylaxis occurred in 0.03% of PT procedures, corresponding to 0.04% of treated cysts, while reversible allergic reactions complicated 1.7% of PTs, corresponding to 1.8% of treated echinococcal cysts. Analysis of the literature shows that lethal anaphylaxis related to percutaneous treatment of CE is an extremely rare event and is observed no more frequently than drug-related anaphylactic side effects. The risk of anaphylactic shock is the objection most often raised by opponents of percutaneous treatments for cystic echinococcosis, but there are no updated figures on the actual occurrence of anaphylaxis as a complication of this treatment. To assess the number of lethal and non-lethal anaphylactic reactions following percutaneous aspiration of echinococcal cysts, we systematically reviewed the literature published from 1980–2010. The analysis of the available literature shows that the risk of severe anaphylactic reactions resulting from percutaneous treatment of echinococcal cysts has been widely exaggerated and the actual risk may be lower than that following administration of certain antibiotics. Provided adequate stand-by resuscitation measures are available, each time an echinococcal cyst is punctured, fear of anaphylactic shock is no longer justified as an argument to avoid this therapeutic option.Keywords
This publication has 46 references indexed in Scilit:
- Symposium on the Definition and Management of Anaphylaxis: Summary reportJournal of Allergy and Clinical Immunology, 2005
- Clinical features and severity grading of anaphylaxisJournal of Allergy and Clinical Immunology, 2004
- Long-term serological evaluation of patients with cystic echinococcosis treated with benzimidazole carbamatesClinical and Experimental Immunology, 2002
- Immunological characterization of Echinococcus granulosus cyclophilin, an allergen reactive with IgE and IgG4 from patients with cystic echinococcosisClinical and Experimental Immunology, 2002
- Diagnosis and Treatment of Hepatic Hydatid Cysts with the Aid of Echo-Guided Percutaneous Cyst PunctureClinical Infectious Diseases, 1995
- Histamine release test in the diagnosis of human hydatidosisClinical & Experimental Allergy, 1989
- Efficacy of Histamine H1 and H2 Receptor Blockers in the Anesthetic Management During Operation for Hydatid Cysts of Liver and LungsSouthern Medical Journal, 1988
- Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 19821986
- Postoperative recurrence of hydatid diseaseBritish Journal of Surgery, 1978
- Anaphylactic Shock during Operation for Hydatid DiseaseAnesthesiology, 1971